EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -11.42
March 31, 2026 -39.69
December 31, 2025 -59.76
September 30, 2025 -69.56
June 30, 2025 -144.27
March 31, 2025 -605.24
December 31, 2024 -19575.72
September 30, 2024 -16365.96
June 30, 2024 -14756.40
March 31, 2024 -10554.30
December 31, 2023 -10390.50
September 30, 2023 -8710.20
June 30, 2023 -4908.60
March 31, 2023 -7465.50
December 31, 2022 -7477.20
September 30, 2022 -5397.30
June 30, 2022 -6554.70
March 31, 2022 -6362.10
December 31, 2021 -8771.40
September 30, 2021 -4682.70
June 30, 2021 -4972.50
March 31, 2021 -5265.00
December 31, 2020 -5124.60
September 30, 2020 -2971.80
June 30, 2020 -3346.20
Date Value
March 31, 2020 -4726.80
December 31, 2019 -4305.60
September 30, 2019 -7195.50
June 30, 2019 -7020.00
March 31, 2019 -8318.70
December 31, 2018 -267731.0
September 30, 2018 -359693.0
June 30, 2018 -389539.7
March 31, 2018 -392640.2
December 31, 2017 -530477.8
September 30, 2017 -514565.9
June 30, 2017 -559142.8
March 31, 2017 -562173.1
December 31, 2016 -274610.6
September 30, 2016 -350999.9
June 30, 2016 -350999.9
March 31, 2016 -280799.9
December 31, 2015 -350999.9
September 30, 2015 -257399.9
June 30, 2015 -386099.9
March 31, 2015 -362699.9
December 31, 2014 -175499.9
September 30, 2014 -187199.9
June 30, 2014 912599.7
March 31, 2014 -187199.9

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Nuwellis, Inc. -26.63
Abbott Laboratories 0.5293
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832

EPS Diluted (Quarterly) Related Metrics